Cisplatin ototoxicity. An electrophysiological dose-effect study in albino guinea pigs

Hearing Research

Volumn 124, Issue 1-2, 1998, Pages 99-107

  Stengs, Cornelis H M ^a   Klis, Sjaak F L ^a   Huizing, Egbert H ^a   Smoorenburg, Guido F ^a  

^a Dept Otorhinolaryngology Univ H ^*  (Netherlands)

Author keywords

Cisplatin; Cochlear microphonics; Compound action potential; Guinea pig; Ototoxicity; Summating potential

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOTROPIN DERIVATIVE;

ACTION POTENTIAL; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; COCHLEA; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; ELECTROOCULOGRAPHY; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; COCHLEAR MICROPHONIC POTENTIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, INNER; ELECTROPHYSIOLOGY; FEMALE; GUINEA PIGS;

EID: 0031728608     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00129-4     Document Type: Article

References (23)

1. Bodenner D.L., Dedon P.C., Keng P.C., Katz J.C., Borch R.F. Selective protection against cis-diamminedichloroplatinum(II) induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer Res. 46:1986;2751-2755.
2. Boughattas N.A., Lévi F., Fournier C., Hecquet B., Lemaigre G., Roulon A., Mathé G., Reinberg A. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice. J. Pharmacol. Exp. Ther. 255:1990;672-679.
3. Carenza L., Villani C., Framarino dei Malatesta M.L., Prosperi Porta R., Millefiorini M., Antonini G., Bolasco P., Bandiera G., Marzetti L. Peripheral neuropathy and ototoxicity of dichlorodiamineplatinum: Instrumental evaluation. Gynecol. Oncol. 25:1986;244-249.
4. Chary K.K., Higby D.J., Henderson E.S., Swinerton K.D. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis. Cancer Treat. Rep. 61:1977;367-370.
5. (4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear. Res. 106:1997;9-19.
6. Gerritsen van der Hoop R., Vecht C.J., Van der Burg M.E.L., Elderson A., Boogerd W., Heimans J.J., Vries E.P., Van Houwelingen J.C., Jennekens F.G.I., Gispen W.H., Neijt J.P. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. New Engl. J. Med. 322:1990;89-94.
7. Gispen W.H. Therapeutic potential for melanocortins in peripheral nerve disease. Trends Pharmacol. Sci. 11:1990;221-222.
8. Hamers F.P.T., Gispen W.H., Neijt J.P. Neurotoxic side-effects of cisplatin. Eur. J. Cancer. 27:1991;372-376.
9. (4-9) analog to affect cisplatin ototoxicity: an electrocochleographic study in guinea pigs. Eur. Arch. Otorhinolaryngol. 251:1994;23-29.
10. Konishi T., Gupta B.N., Prazma J. Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs. Am. J. Otolaryngol. 4:1983;18-26.
11. Laurell G., Engström B. The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hear. Res. 38:1989;27-34.
12. McAlpine D., Johnstone B.M. The ototoxic mechanism of cisplatin. Hear. Res. 47:1990;191-204.
13. McHaney V.A., Thibadoux G., Hayes F.A., Green A.A. Hearing loss in children receiving cisplatin chemotherapy. J. Pediatr. 102:1983;314-317.
14. Nakai Y., Konishi K., Chang K.C., Ohashi K., Morisaki N., Minowa Y., Morimoto A. Ototoxicity of the anticancer drug cisplatin. Acta Otolaryngol. (Stockh.). 93:1982;227-232.
15. Otto W.C., Brown R.D., Gage-White L., Kupetz S., Anniko M., Penny J.E., Henly C.M. Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hear. Res. 35:1988;79-86.
16. Pfeifle C.E., Howell S.B., Felthouse R.D., Woliver T.B.S., Andrews P.A., Markman M., Murphy M.P. High-dose cisplatin with sodium thiosulfate protection. J. Clin. Oncol. 3:1985;237-244.
17. Saito T., Aran J.M. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL. 56:1994;315-320.
18. Schaefer S.D., Post J.D., Close L.G., Wright C.G. Ototoxicity of low- and moderate-dose cisplatin. Cancer. 56:1985;1934-1939.
19. Schweitzer V.G. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope. 103:(Suppl. 59):1993;1-52.
20. Stengs C.H.M., Klis S.F.L., Huizing E.H., Smoorenburg G.F. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig. Hear. Res. 111:1997;103-113.
21. van Deelen G.W., Smoorenburg G.F. Electrocochleography for different electrode positions in guinea pig. Acta Otolaryngol. (Stockh.). 101:1986;207-216.
22. van der Hulst R.J.A.M., Dreschler W.A., Urbanus N.A.M. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivates. Ann. Otol. Rhinol. Laryngol. 97:1988;133-137.
23. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur. J. Neurosci. 8:1996;1897-1905.